九典制药：关于完成工商变更登记的公告

Core Viewpoint - The company announced the completion of changes to its registered capital and the revision of related articles, following the approval at the first extraordinary shareholders' meeting of 2025 held on September 9, 2025 [1] Group 1 - The company has completed the business registration change procedures and obtained a new business license issued by the Changsha Market Supervision Administration [1]